224 related articles for article (PubMed ID: 17123922)
1. Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin.
Lecaroz C; Gamazo C; Renedo MJ; Blanco-Prieto MJ
J Microencapsul; 2006 Nov; 23(7):782-92. PubMed ID: 17123922
[TBL] [Abstract][Full Text] [Related]
2. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
Prior S; Gamazo C; Irache JM; Merkle HP; Gander B
Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713
[TBL] [Abstract][Full Text] [Related]
3. Release mechanisms from gentamicin loaded poly(lactic-co-glycolic acid) (PLGA) microparticles.
Friess W; Schlapp M
J Pharm Sci; 2002 Mar; 91(3):845-55. PubMed ID: 11920769
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers with gentamicin to treat intracellular pathogens.
Lecaroz C; Gamazo C; Blanco-Prieto MJ
J Nanosci Nanotechnol; 2006; 6(9-10):3296-302. PubMed ID: 17048550
[TBL] [Abstract][Full Text] [Related]
5. Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice.
Lecaroz MC; Blanco-Prieto MJ; Campanero MA; Salman H; Gamazo C
Antimicrob Agents Chemother; 2007 Apr; 51(4):1185-90. PubMed ID: 17220415
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of gentamicin released from microparticles.
Blanco-Príeto MJ; Lecaroz C; Renedo MJ; Kunkova J; Gamazo C
Int J Pharm; 2002 Aug; 242(1-2):203-6. PubMed ID: 12176247
[TBL] [Abstract][Full Text] [Related]
7. Controlled delivery of a hydrophilic drug from a biodegradable microsphere system by supercritical anti-solvent precipitation technique.
Lee S; Kim MS; Kim JS; Park HJ; Woo JS; Lee BC; Hwang SJ
J Microencapsul; 2006 Nov; 23(7):741-9. PubMed ID: 17123918
[TBL] [Abstract][Full Text] [Related]
8. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
9. Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin.
Lecároz C; Blanco-Prieto MJ; Burrell MA; Gamazo C
J Antimicrob Chemother; 2006 Sep; 58(3):549-56. PubMed ID: 16799160
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure.
McCarron PA; Donnelly RF; Marouf W
J Microencapsul; 2006 Aug; 23(5):480-98. PubMed ID: 16980271
[TBL] [Abstract][Full Text] [Related]
11. Formulation and evaluation of sustained release microspheres of poly-lactide-co-glycolide containing tamoxifen citrate.
Sehra S; Dhake AS
J Microencapsul; 2005 Aug; 22(5):521-8. PubMed ID: 16361195
[TBL] [Abstract][Full Text] [Related]
12. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics.
Bittner B; Morlock M; Koll H; Winter G; Kissel T
Eur J Pharm Biopharm; 1998 May; 45(3):295-305. PubMed ID: 9653634
[TBL] [Abstract][Full Text] [Related]
14. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release.
Naraharisetti PK; Lew MD; Fu YC; Lee DJ; Wang CH
J Control Release; 2005 Feb; 102(2):345-59. PubMed ID: 15653156
[TBL] [Abstract][Full Text] [Related]
15. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G
Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of PLGA microparticle properties loaded with micronized, nanosized or dissolved drug.
Zhang C; Bodmeier R
Int J Pharm; 2022 Nov; 628():122313. PubMed ID: 36272513
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: Part III. Drug delivery application.
Wu XS
Artif Cells Blood Substit Immobil Biotechnol; 2004; 32(4):575-91. PubMed ID: 15974184
[TBL] [Abstract][Full Text] [Related]
18. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells.
Intra J; Salem AK
J Drug Target; 2011 Jul; 19(6):393-408. PubMed ID: 20681752
[TBL] [Abstract][Full Text] [Related]
19. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T
J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery.
Haddadi A; Farboud ES; Erfan M; Aboofazeli R
J Microencapsul; 2006 Sep; 23(6):698-712. PubMed ID: 17118885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
